Key parts of the immune system can remember the coronavirus SARS-CoV-2, the virus that causes COVID-19, for at least eight or nine months, possibly for years.
The gene expression and chromatin accessibility atlases will accelerate the study of the genomics of normal and abnormal development.
Data and safety monitoring boards (DSMBs) are supposed to make sure the medicine is safe and it works and they can halt a clinical trial or fast-track it.
UW researchers found that levels of metabolites provide a key to understanding why some organisms respond to low-calorie life-extension diets and others do not.
Findings may help explain why these energy-producing cellular organelles begin to fail as we age.
From the research lab to your doctor’s office – here’s what happens in phase 1, 2, 3 drug trials
Working in a biosafety level 4 las, Fischer and her team image the world’s deadliest pathogens from Ebola to HIV, salmonella to COVID-19 virus–SARS-CoV-2.
Patients and staff at UW Medical Center participated in the international trial, which has ended. Preliminary findings were published Friday.
Scent molecules can mask other scents, not by overpowering them, but by changing the way cells respond to them
The study will follow patients who contract COVID-19 to learn why some die, some recover, and some are asymptomatic.
The phone app could diagnose illness sooner, preventing members of the military and civilians who are ill from returning to work or school too soon.
Researchers are investigating whether hydroxychloroquine, a commonly used anti-malarial and autoimmune-disease treatment, can prevent COVID-19.
Instead of trying to create a new drug, some scientists are looking to see if there are any drugs available today that can fight the coronavirus.
By David Armstrong, Annie Waldman and Daniel GoldenProPublica ProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story newsletter to receive stories like this one in your inbox. On the fourth floor of the University of Florida…
A huge proportion of medical research is funded by industry even though studies show company-sponsored studies tend to overstate benefits, playdown harms.